UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 854

Sortiert nach

1004. Frequency of Occurrence and Antimicrobial Susceptibility of Bacteria Isolated From Patients Hospitalized With Bloodstream Infections in United States Medical Centers (2015–2017)

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S299-S299

2018

Link zum Volltext

Verfügbarkeit prüfen

1076. Activity of Rezafungin and Comparator Antifungal Agents Tested Against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019-2020)

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S628-S628

2021

Link zum Volltext

Verfügbarkeit prüfen

1081. Antimicrobial Activity of Dalbavancin Tested Against Gram-Positive Organisms Isolated From Patients With Infective Endocarditis in United States and European Medical Centers

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S323-S323

2018

Link zum Volltext

Verfügbarkeit prüfen

1240. Ceftobiprole Activity against Drug-Resistant Staphylococcus aureus Clinical Isolates Collected in the United States from 2016 through 2020

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S709-S710

2021

Link zum Volltext

Verfügbarkeit prüfen

1253. In Vitro Activity of Omadacycline against 7000 Bacterial Pathogens from the United States Stratified by Infection Type (2019)

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S644-S644

2020

Link zum Volltext

Verfügbarkeit prüfen

1258. Activity of a Series of Investigational Compounds Tested Against Invasive Fungal Isolates

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S645-S646

2020

Link zum Volltext

Verfügbarkeit prüfen

1260. Activity of Manogepix (APX001A) against 2,669 Fungal Isolates from the SENTRY Surveillance Program (2018-2019) Stratified by Infection Type

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S646-S647

2020

Link zum Volltext

Verfügbarkeit prüfen

1292. Activity of Omadacycline and Comparators Against 876 Bacterial Clinical Isolates from Patients with Bone and Joint Infections in the United States and Europe (2015–2022)

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Link zum Volltext

Verfügbarkeit prüfen

1454Antifungal Susceptibility Patterns of a Global Collection of Fungal Isolates and Polysorbate-80 Effect on the Susceptibility of the Antifungal Classes

Open forum infectious diseases, 2014-12, Vol.1 (suppl_1), p.S383-S383

2014

Link zum Volltext

Verfügbarkeit prüfen

1590. Updated Aminoglycoside (AG) MIC Breakpoints (BP) to Minimize Adverse Events and Improve Outcome: Impact on Susceptibility (S) Rates

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S580-S580

2019

Link zum Volltext

Verfügbarkeit prüfen

1591. Updated Fluoroquinolone MIC Breakpoints: Impact on Susceptibility Rates in the United States

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S580-S581

2019

Link zum Volltext

Verfügbarkeit prüfen

1595. Ceftobiprole Activity against Gram-Positive Pathogens Causing Bone and Joint Infections in the United States from 2016 through 2019

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S794-S794

2020

Link zum Volltext

Verfügbarkeit prüfen

A 1994–1995 survey of Haemophilus influenzae susceptibility to ten orally administered agents A 187 clinical laboratory center sample in the United States

Diagnostic microbiology and infectious disease, 1997-03, Vol.27 (3), p.75-83

1997

Link zum Volltext

Verfügbarkeit prüfen

A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents : A 187 clinical laboratory center sample in the United States

Diagnostic microbiology and infectious disease, 1997-03, Vol.27 (3), p.75-83

1997

Link zum Volltext

Verfügbarkeit prüfen

2043. In Vitro Activity of Manogepix Against 2,810 Fungal Isolates from the SENTRY Surveillance Program (2020-2021) Stratified by Infection Type

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Link zum Volltext

Verfügbarkeit prüfen

2044. In Vitro Activity of Omadacycline Against 14,000 Bacterial Isolates from the United States by Infection Type (2020-2021)

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Link zum Volltext

Verfügbarkeit prüfen

2115. Activity of a Long-Acting Echinocandin Rezafungin and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates: SENTRY 2018

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S716-S716

2019

Link zum Volltext

Verfügbarkeit prüfen

2400. Activity of a Long-Acting Echinocandin, Rezafungin, Tested Against Invasive Fungal Isolates Collected Worldwide

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S716-S717

2018

Link zum Volltext

Verfügbarkeit prüfen

3172 – VIRAL RESPIRATORY INFECTION INDUCES EMERGENCY MEGAKARYOPOIESIS AND GENERATES HYPER-REACTIVE PLATELETS BY A THROMBOPOIETIN INDEPENDENT MECHANISM

Experimental hematology, 2022, Vol.111, p.S130-S131

2022

Link zum Volltext

Verfügbarkeit prüfen

347. Azole Activity against Filamentous Fungi Causing Invasive Infections in Patients from ICU and Non-ICU Units (2017-2021)

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Link zum Volltext

Verfügbarkeit prüfen

378. Candida auris Fungemia: Risk Factors and Outcome

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S147-S147

2018

Link zum Volltext

Verfügbarkeit prüfen

3D Versus 2D Cell Culture

Methods in Cell Biology, 2010, Vol.96, p.649-670

2010

Link zum Volltext

Verfügbarkeit prüfen

3D versus 2D cell culture implications for electron microscopy

Methods in cell biology, 2010, Vol.96, p.649-670

2010

Link zum Volltext

Verfügbarkeit prüfen

665. In vitro Activity of Omadacycline Against Recent (2018) Bacterial Pathogens from the United States and Europe Obtained from Skin and Skin Structure, Respiratory, and Urinary Tract Infections

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S305-S305

2019

Link zum Volltext

Verfügbarkeit prüfen

868. In Vitro Activity of Isavuconazole and Other Mould-Active Triazoles Against Aspergillus fumigatus With and Without cyp51 Alterations

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 854

Suche als RSS-Feed

Aktive Filter

ThemaMycology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(634)
Mit Volltextzugriff
(740)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(479)
Life Sciences & Biomedicine
(460)
Humans
(336)
Microbiology
(325)
Infectious Diseases
(288)
Biological And Medical Sciences
(273)
Medical Sciences
(232)
Microbial Sensitivity Tests
(177)
Pharmacology. Drug Treatments
(142)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(137)
Pharmacology & Pharmacy
(119)
Anti-Bacterial Agents - Pharmacology
(95)
Antifungal Agents - Pharmacology
(88)
Antibacterial Agents
(79)
Fundamental And Applied Biological Sciences. Psychology
(77)
Male
(75)
Epidemiology
(72)
Female
(71)
Infections
(68)
Antifungal Agents
(67)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

1004. Frequency of Occurrence and Antimicrobial Susceptibility of Bacteria Isolated From Patients Hospitalized With Bloodstream Infections in United States Medical Centers (2015–2017)

1076. Activity of Rezafungin and Comparator Antifungal Agents Tested Against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019-2020)

1081. Antimicrobial Activity of Dalbavancin Tested Against Gram-Positive Organisms Isolated From Patients With Infective Endocarditis in United States and European Medical Centers

1240. Ceftobiprole Activity against Drug-Resistant Staphylococcus aureus Clinical Isolates Collected in the United States from 2016 through 2020

1253. In Vitro Activity of Omadacycline against 7000 Bacterial Pathogens from the United States Stratified by Infection Type (2019)

1258. Activity of a Series of Investigational Compounds Tested Against Invasive Fungal Isolates

1260. Activity of Manogepix (APX001A) against 2,669 Fungal Isolates from the SENTRY Surveillance Program (2018-2019) Stratified by Infection Type

1292. Activity of Omadacycline and Comparators Against 876 Bacterial Clinical Isolates from Patients with Bone and Joint Infections in the United States and Europe (2015–2022)

1454Antifungal Susceptibility Patterns of a Global Collection of Fungal Isolates and Polysorbate-80 Effect on the Susceptibility of the Antifungal Classes

1590. Updated Aminoglycoside (AG) MIC Breakpoints (BP) to Minimize Adverse Events and Improve Outcome: Impact on Susceptibility (S) Rates

1591. Updated Fluoroquinolone MIC Breakpoints: Impact on Susceptibility Rates in the United States

1595. Ceftobiprole Activity against Gram-Positive Pathogens Causing Bone and Joint Infections in the United States from 2016 through 2019

A 1994–1995 survey of Haemophilus influenzae susceptibility to ten orally administered agents A 187 clinical laboratory center sample in the United States

A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents : A 187 clinical laboratory center sample in the United States

2043. In Vitro Activity of Manogepix Against 2,810 Fungal Isolates from the SENTRY Surveillance Program (2020-2021) Stratified by Infection Type

2044. In Vitro Activity of Omadacycline Against 14,000 Bacterial Isolates from the United States by Infection Type (2020-2021)

2115. Activity of a Long-Acting Echinocandin Rezafungin and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates: SENTRY 2018

2400. Activity of a Long-Acting Echinocandin, Rezafungin, Tested Against Invasive Fungal Isolates Collected Worldwide

3172 – VIRAL RESPIRATORY INFECTION INDUCES EMERGENCY MEGAKARYOPOIESIS AND GENERATES HYPER-REACTIVE PLATELETS BY A THROMBOPOIETIN INDEPENDENT MECHANISM

347. Azole Activity against Filamentous Fungi Causing Invasive Infections in Patients from ICU and Non-ICU Units (2017-2021)

378. Candida auris Fungemia: Risk Factors and Outcome

3D Versus 2D Cell Culture

3D versus 2D cell culture implications for electron microscopy

665. In vitro Activity of Omadacycline Against Recent (2018) Bacterial Pathogens from the United States and Europe Obtained from Skin and Skin Structure, Respiratory, and Urinary Tract Infections

868. In Vitro Activity of Isavuconazole and Other Mould-Active Triazoles Against Aspergillus fumigatus With and Without cyp51 Alterations

Aktive Filter

Suchergebnisse filtern